These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6392833)

  • 1. Lethal effect of neutral mannan fraction of bakers' yeast in mice.
    Nagase T; Mikami T; Suzuki S; Schuerch C; Suzuki M
    Microbiol Immunol; 1984; 28(9):997-1007. PubMed ID: 6392833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of platelet-activating factor in mice by intravenous administration of a neutral fraction of bakers' yeast mannan.
    Mikami T; Fukushi K; Ishitani M; Ishitani K; Suzuki S; Suzuki M
    Lipids; 1991 Dec; 26(12):1404-7. PubMed ID: 1819741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effect of acidic mannan fraction of bakers' yeast against Staphylococcus aureus infection in mice.
    Okawa Y; Okura Y; Hashimoto K; Suzuki K; Suzuki S; Suzuki M
    J Pharmacobiodyn; 1985 Nov; 8(11):942-7. PubMed ID: 3912489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of acidic mannan fraction of bakers' yeast on experimental candidiasis in mice.
    Okawa Y; Suzuki K; Kobayashi M; Asagi M; Sakai K; Suzuki S; Suzuki M
    Microbiol Immunol; 1986; 30(10):957-67. PubMed ID: 3025567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor activity of acidic mannan fraction from bakers' yeast.
    Hashimoto K; Okawa Y; Suzuki K; Okura Y; Suzuki S; Suzuki M
    J Pharmacobiodyn; 1983 Sep; 6(9):668-76. PubMed ID: 6317837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of leukotrienes from mouse peritoneal macrophages by treatment with a neutral subfraction of bakers' yeast mannan.
    Ishitani K; Harakawa M; Mikami T; Nagase T; Suzuki S; Suzuki M
    J Pharmacobiodyn; 1988 May; 11(5):363-8. PubMed ID: 2902208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of interleukin-1 activity of Kupffer cells from mice treated with the acidic mannan fraction of baker's yeast.
    Okawa Y; Abe K; Watanabe T; Sasaki H; Suzuki M
    Biol Pharm Bull; 2002 Nov; 25(11):1506-8. PubMed ID: 12419972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between phosphate content and immunochemical properties of subfractions of bakers' yeast mannan.
    Okubo Y; Ichikawa T; Suzuki S
    J Bacteriol; 1978 Oct; 136(1):63-8. PubMed ID: 361709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of baker's yeast mannan against Listeria monocytogenes and Pseudomonas aeruginosa infection in mice.
    Kobayashi M; Okawa Y; Suzuki S; Suzuki M
    Chem Pharm Bull (Tokyo); 1990 Mar; 38(3):807-9. PubMed ID: 2189582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro cytolysis of MM46 tumor cells by mouse phagocytes activated by acidic mannan fraction of bakers' yeast.
    Hashimoto K; Okawa Y; Mikami T; Suzuki S; Suzuki M
    J Pharmacobiodyn; 1984 Jul; 7(7):472-8. PubMed ID: 6491865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimetastatic effect of yeast mannan-bleomycin conjugate against mouse Lewis lung carcinoma.
    Konno Y; Takahashi S; Naruse R; Mikami T; Matsumoto T; Suzuki S; Suzuki M
    Biol Pharm Bull; 1994 May; 17(5):748-52. PubMed ID: 7522733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor effect of a baker's yeast mannan-mitomycin C conjugate against mouse hepatoma, MH134, in vivo and in vitro.
    Aizawa K; Matsumoto T; Tsukada K; Ito A; Sato H; Suzuki S; Suzuki M
    Int J Immunopharmacol; 1989; 11(2):191-5. PubMed ID: 2467888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyrogenicity of yeast mannans in rabbits.
    Nagase T; Mikami T; Suzuki S; Suzuki M
    Microbiol Immunol; 1984; 28(6):651-7. PubMed ID: 6384740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunochemical studies of the mannans of Saccharomyces cerevisiae X2180-1A-5 and Saccharomyces cerevisiae 4484-24D-1 mutant strains, with special reference to their phosphate content.
    Okubo Y; Shibata N; Matsumoto T; Suzuki M; Schuerch C; Suzuki S
    J Bacteriol; 1980 Oct; 144(1):92-6. PubMed ID: 6158512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth-inhibitory activity of the D-mannan of Saccharomyces cerevisiae X2180-1A-5 mutant strain against mouse-implanted sarcoma 180 and Ehrlich-carcinoma solid tumor.
    Matsumoto T; Takanohashi M; Okubo Y; Suzuki M; Suzuki S
    Carbohydr Res; 1980 Aug; 83(2):363-70. PubMed ID: 6996813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of D-mannan of bakers' yeast against Staphylococcus aureus infection in mice.
    Okawa Y; Okura Y; Hashimoto K; Matsumoto T; Suzuki S; Suzuki M
    Carbohydr Res; 1982 Oct; 108(2):328-34. PubMed ID: 6754079
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification of two Saccharomyces cerevisiae cell wall mannan chemotypes.
    Cawley TN; Ballou CE
    J Bacteriol; 1972 Sep; 111(3):690-5. PubMed ID: 4559821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytolytic effect of macrophages and polymorphonuclear leukocytes treated with acidic fraction of bakers' yeast mannan against MM46 tumor cells in vitro.
    Sakai K; Suzuki S; Suzuki M
    J Pharmacobiodyn; 1984 Dec; 7(12):943-50. PubMed ID: 6335896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitogenic effect of the mannans from Saccharomyces cerevisiae on mouse spleen lymphocytes.
    Mikami T; Nagase T; Matsumoto T; Suzuki M; Suzuki S; Kumano N
    Microbiol Immunol; 1982; 26(10):913-22. PubMed ID: 6761557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunochemical study on bakers' yeast mannan prepared by fractional precipitation with cetyltrimethylammonium bromide.
    Okubo Y; Shibata N; Ichikawa T; Chaki S; Suzuki S
    Arch Biochem Biophys; 1981 Nov; 212(1):204-15. PubMed ID: 7030219
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.